|
 Theranos has filed a notice of intent to appeal sanctions imposed by
the Centers for Medicare and Medicaid Services (CMS) on the
company's lab in Newark, California, the privately held company said
late Thursday.
Theranos was not conducting any patient testing at the Newark lab
and has taken measures including enhancing clinical policies and
procedures and revamping training programs, to rectify the issues
CMS identified, it said in a statement.
CMS revoked a key certificate for the lab in July and terminated the
facility's approval to receive Medicare and Medicaid payments for
all services.
Medicare is the government's medical insurance program for the
elderly, while Medicaid is for the poor.
The sanctions, which also include an unspecified monetary penalty,
came six months after the regulator sent a scathing letter to the
company criticizing its practices.
The Palo Alto, California-based company ran into trouble after the
Wall Street Journal published a series of articles beginning October
that suggested its devices were flawed.
[to top of second column] |
Theranos was founded by CEO Elizabeth Holmes in 2003 to develop a
blood-testing device that would deliver quicker results using only a
drop of blood.
(Reporting by Vishal Sridhar in Bengaluru; Editing by Amrutha
Gayathri)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
 |
